Classer les publications sur l'année
-
Pharmaco-Epidémiologie
Air, pollution et cancer : baromĂštre de pollutions en France
NEROME S, QUOIX E, DUBURCQ A
Carnet de routes-Editions Bash ; 1-17
-
Pharmaco-Epidémiologie
A survey on the prevalence of orofacial herpes in France : The INSTANT Study
LORETTE G, CROCHARD A, MIMAUD V, WOLKENSTEIN P, STALDER JF, EL HASNAOUI A
J Am Acad Dermatol ; 55(2):225-232
-
Pharmaco-Epidémiologie
Venous thromboembolism and mortality after hip fracture surgery : The ESCORTE Study
ROSENCHER N, VIELPEAU C, EMMERICH J, FAGNANI F, SAMAMAÂ CM, The ESCORTE Group
J Thromb Haemost ; 3(9):2006-2014
-
Pharmaco-Epidémiologie
Results from the observational study EPIGRAM : management of excess weight in general practice and follow-up of patients treatd with orlistat
VRAY M, JOUBERT JM, ESCHWEGE E, LIARD F, FAGNANI F, MONTESTRUC F, FAGES S, BEGAUD B
Thérapie ; 60(1):153-162
-
Pharmaco-Epidémiologie
Prise en charge de la douleur en mĂ©decine gĂ©nĂ©rale : l’Ă©tude EPIDOL
EMERY C, GEORGE B, GOMAS JM, DELFIEU D, MIMAUD V, GUILLON P, FAGNANI F
Douleurs ; 6(6):366-373
-
Pharmaco-Epidémiologie
Prévalence de la bronchopneumopathie chronique obstructive (BPCO) : estimation pour la France
BENARD E, DETOURNAY B, NEUKIRCH F, PRIBIL C, EL HASNAOUI A
La Lettre du Pneumologue ; 8(4):158-163
-
Pharmaco-Epidémiologie
Prevalence and burden of self-reported blindness, low vision, and visual impairment in the French community : a nationwide survey
BREZIN AP, LAFUMA A, FAGNANI F, MESBAH M, BERDEAUX G
Arch Ophtalmol ; 123(8):1117-1124
-
Pharmaco-Epidémiologie
Prevalence and burden of self-reported blindness and low vision for individuals living in institutions : a nationwide survey
BREZIN AP, LAFUMA A, FAGNANI F, MESBAH M, BERDEAUX G
Health and Quality of Life Outcomes ; 3(27)
-
Pharmaco-Epidémiologie
Incidence of Herpes Simplex Virus Keratitis In France
LABETOULLE M, AUQUIER P, CONRAD H, CROCHARD A, DANILOSKI M, BOUEE S, EL HASNAOUI A, COLIN J
Ophtalmology ; 112(5):888-895
-
Pharmaco-Epidémiologie
Identification des freins au dĂ©pistage et Ă la prise en charge des patients infectĂ©s par le virus de l’hĂ©patite C : Etude Gymkhana 1, France, 9 au 12 dĂ©cembre 2002
BENTATA M, AUBERT JP, BOUEE S, COMPAGNON M, ELGHOZI B, LIVROZET JM, MECHALI D, PERDRIEAU F, PY AM, ROZEMBAUM W, TAULERA O, WAJSBROT A
BEH ; 43:215-216
-
Pharmaco-Epidémiologie
Epidemiology of restless legs syndrome in French adults A nationwide survey: The INSTANT Study
TISON F, CROCHARD A, LEGER D, BOUEE S, LAINEY E, EL HASNAOUI A
Neurology ; 65:239-246
-
Pharmaco-Epidémiologie
Epidemiology and costs of diabetes treated with insulin in France
DETOURNAY B, RACCAH D, CADILHAC M, ESCHWEGE E
Diabetes Metab ; 31(2):S1-S18
-
Pharmaco-Epidémiologie
Epidémiologie de la maladie thromboembolique veineuse
BENARD E, LAFUMA A, RAVAUD P
Presse Med ; 2005;34(6):415-419
-
Pharmaco-Epidémiologie
Effects of dyskinesias in Parkinson’s disease on quality of life and health-related costs : a prospective European study
PECHEVIS C, CLARKE E, VIEREGGE P, KHOSHNOOD B, DESCHASEAUX-VOINET C, BERDEAUX G, ZIEGLER M
Eur J Neurol ; 12:956-963
-
Pharmaco-Epidémiologie
DĂ©pistage de l’infection parle VHC en mĂ©decine gĂ©nĂ©rale
AUBERT JP, BOUEE S, BENTATA M, COMPAGNON M, ELGHOZI B, LIVROZET JM, MECHALI D, PERDRIEAU F, PY AM, ROZEMBAUM W, TAULERA O, WAJSBROT A
La Revue du Praticien ; 19:895-899